BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 36714647)

  • 1. A deep intronic splice variant of the
    Qian P; Bao Y; Huang HM; Suo L; Han Y; Li ZJ; Zhang M
    Front Pediatr; 2022; 10():1009188. PubMed ID: 36714647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant Splicing of
    Li Y; Yan X; Luo Z; Fu X; Li Z; Xu Q; Chen J; Yang J; Lu D
    Int J Nephrol Renovasc Dis; 2024; 17():167-174. PubMed ID: 38855711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
    Malone AF; Funk SD; Alhamad T; Miner JH
    Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and molecular dynamics analysis of two variants of the COL4A5 gene causing Alport syndrome.
    Liang L; Wu H; Cai Z; Zhao J
    BMC Med Genomics; 2023 Aug; 16(1):192. PubMed ID: 37596645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics and minigene assay of new splicing variant c.4298-20T>A of
    Liang L; Wu H; Cai Z; Zhao J
    Front Genet; 2023; 14():1059322. PubMed ID: 36923787
    [No Abstract]   [Full Text] [Related]  

  • 7. The NM_033380.2 transcript of the
    Liang L; Wu H; Zhao J
    Front Genet; 2024; 15():1330525. PubMed ID: 38818038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-linked Alport syndrome caused by splicing mutations in COL4A5.
    Nozu K; Vorechovsky I; Kaito H; Fu XJ; Nakanishi K; Hashimura Y; Hashimoto F; Kamei K; Ito S; Kaku Y; Imasawa T; Ushijima K; Shimizu J; Makita Y; Konomoto T; Yoshikawa N; Iijima K
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1958-64. PubMed ID: 25183659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Four Novel
    Wang S; Shao Y; Wang Y; Lu J; Shao L
    Front Genet; 2022; 13():847777. PubMed ID: 35368650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional assessment of a novel
    Chen X; Ye N; Zhang L; Zheng W; Cheng J; Gong M
    Ann Transl Med; 2021 Sep; 9(18):1420. PubMed ID: 34733972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel COL4A5 splicing mutation causes alport syndrome in a Chinese family.
    Chen S; Xu G; Zhao Z; Du J; Shen B; Li C
    BMC Med Genomics; 2024 Apr; 17(1):108. PubMed ID: 38671472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Contribution of
    Yamamura T; Horinouchi T; Aoto Y; Lennon R; Nozu K
    Front Med (Lausanne); 2022; 9():841391. PubMed ID: 35211492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The First COL4A5 Exon 41A Glycine Substitution in a Family With Alport Syndrome.
    Wang F; Zhao D; Ding J; Li X
    Front Pediatr; 2020; 8():153. PubMed ID: 32328471
    [No Abstract]   [Full Text] [Related]  

  • 14. A COL4A5 Missense Variant in a Han-Chinese Family with X-linked Alport Syndrome.
    Wu Y; Guo Y; Yuan J; Xu H; Chen Y; Zhang H; Yuan M; Deng H; Yuan L
    Curr Mol Med; 2019; 19(10):758-765. PubMed ID: 31490752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
    Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
    Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disease-causing variant of COL4A5 in a Chinese family with Alport syndrome: a case series.
    Wu J; Zhang J; Liu L; Zhang B; Yamamura T; Nozu K; Matsuo M; Zhao J
    BMC Nephrol; 2021 Nov; 22(1):380. PubMed ID: 34774011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic analysis and in vitro validation of a case of Alport syndrome due to a splicing variant of COL4A5 gene].
    Liang L; Cai Z; Wu H; Meng H; Zhao J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Oct; 40(10):1263-1269. PubMed ID: 37730228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic and clinical analysis of a pedigree affected with X-linked dominant Alport syndrome due to a novel variant of COL4A5 gene].
    Ma Q; Wu J; Che L; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 May; 38(5):461-464. PubMed ID: 33974256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of mutations in the COL4A5 gene by analyzing cDNA of skin fibroblasts.
    Wang F; Wang Y; Ding J; Yang J
    Kidney Int; 2005 Apr; 67(4):1268-74. PubMed ID: 15780079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic evaluation of synonymous COL4A5 variants in X-linked Alport syndrome using a minigene assay.
    Horinouchi T; Yamamura T; Minamikawa S; Nagano C; Sakakibara N; Nakanishi K; Shima Y; Morisada N; Ishiko S; Aoto Y; Nagase H; Takeda H; Rossanti R; Ishimori S; Kaito H; Matsuo M; Iijima K; Nozu K
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1342. PubMed ID: 32543079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.